{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:28:28Z","timestamp":1786980508096,"version":"build-2736575974"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009282","name":"United Mitochondrial Disease Foundation","doi-asserted-by":"publisher","award":["2021 accelerator prize"],"award-info":[{"award-number":["2021 accelerator prize"]}],"id":[{"id":"10.13039\/100009282","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021778","name":"Agencia Nacional de Promoci\u00f3n de la Investigaci\u00f3n, el Desarrollo Tecnol\u00f3gico y la Innovaci\u00f3n","doi-asserted-by":"publisher","award":["2019-00449"],"award-info":[{"award-number":["2019-00449"]}],"id":[{"id":"10.13039\/501100021778","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007030","name":"Ministerio de Ciencia y Tecnolog\u00eda, Gobierno de la Provincia de C\u00f3rdoba","doi-asserted-by":"publisher","award":["Gen\u00f3mica Cl\u00ednica de Enfermedades Poco frecuentes"],"award-info":[{"award-number":["Gen\u00f3mica Cl\u00ednica de Enfermedades Poco frecuentes"]}],"id":[{"id":"10.13039\/501100007030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY010804"],"award-info":[{"award-number":["R01EY010804"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000183","name":"Army Research Office","doi-asserted-by":"crossref","award":["W911NF-21-1-0248"],"award-info":[{"award-number":["W911NF-21-1-0248"]}],"id":[{"id":"10.13039\/100000183","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["MDA 964119"],"award-info":[{"award-number":["MDA 964119"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research to Prevent Blindness Stein award and the Florida Biomedical Foundation","award":["21K05"],"award-info":[{"award-number":["21K05"]}]},{"DOI":"10.13039\/501100000157","name":"International Union of Biochemistry and Molecular Biology","doi-asserted-by":"publisher","award":["Wood-Whelan research fellowship 2019"],"award-info":[{"award-number":["Wood-Whelan research fellowship 2019"]}],"id":[{"id":"10.13039\/501100000157","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2025,9,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mitochondrial diseases, caused by mutations in nuclear or mitochondrial DNA (mtDNA), have limited treatment options. For mtDNA mutations, reducing the mutant-to-wild-type mtDNA ratio (heteroplasmy shift) is a promising strategy, though it currently faces challenges. Previous research showed that severe mitochondrial dysfunction triggers an adaptive nuclear epigenetic response, through changes in DNA methylation, absent or less important for subtle mitochondrial impairment. Therefore, we hypothesized that targeting nuclear DNA methylation could impair cells with high-mutant mtDNA load while sparing those with lower levels, reducing overall heteroplasmy. Using cybrid models harboring two disease-causing mtDNA mutations\u2014m.13513\u2009G\u2009&gt;\u2009A and m.8344\u2009A\u2009&gt;\u2009G\u2014at varying heteroplasmies, we discovered that both the mutation type and load distinctly shape the nuclear DNA methylome. We found this methylation pattern critical for the survival of high-heteroplasmy cells but not for low-heteroplasmy ones. Treatment with FDA-approved DNA methylation inhibitors selectively impacted high-heteroplasmy cybrids and reduced heteroplasmy. These findings were validated in cultured cells and xenografts. Our findings highlight nuclear DNA methylation as a key regulator of heteroplasmic cell survival and a potential therapeutic target for mitochondrial diseases.<\/jats:p>","DOI":"10.1038\/s44321-025-00285-5","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T15:16:52Z","timestamp":1754925412000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Rewriting nuclear epigenetic scripts in mitochondrial diseases as a strategy for heteroplasmy control"],"prefix":"10.1038","volume":"17","author":[{"given":"Mar\u00eda J","family":"P\u00e9rez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6536-194X","authenticated-orcid":false,"given":"Roc\u00edo B","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7286-2724","authenticated-orcid":false,"given":"Sebasti\u00e1n M","family":"Real","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda T","family":"Branham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1954-7033","authenticated-orcid":false,"given":"Sergio R","family":"Laurito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8077-7092","authenticated-orcid":false,"given":"Carlos T","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7453-4919","authenticated-orcid":false,"given":"L\u00eda","family":"Mayorga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"285_CR1","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41594-023-01181-7","volume":"31","author":"J Achinger-Kawecka","year":"2024","unstructured":"Achinger-Kawecka J, Stirzaker C, Portman N, Campbell E, Chia KM, Du Q, Laven-Law G, Nair SS, Yong A, Wilkinson A et al (2024) The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer. Nat Struct Mol Biol 31:498\u2013512","journal-title":"Nat Struct Mol Biol"},{"key":"285_CR2","doi-asserted-by":"crossref","first-page":"w14523","DOI":"10.4414\/smw.2017.14523","volume":"147","author":"B Adrian","year":"2017","unstructured":"Adrian B (2017) Genetic determinants of the epigenome in development and cancer. Swiss Med Wkly 147:w14523","journal-title":"Swiss Med Wkly"},{"key":"285_CR3","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-64664-3","volume":"10","author":"A Aminuddin","year":"2020","unstructured":"Aminuddin A, Ng PY, Leong CO, Chua EW (2020) Mitochondrial DNA alterations may influence the cisplatin responsiveness of oral squamous cell carcinoma. Sci Rep 10:7885","journal-title":"Sci Rep"},{"key":"285_CR4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.17116\/oftalma2022138052208","volume":"138","author":"NA Andreeva","year":"2022","unstructured":"Andreeva NA, Murakhovskaya YK, Tsygankova PG, Krilova TD, Sheremet NL (2022) [Leber\u2019s hereditary optic neuropathy clinical features in patients with mitochondrial DNA m.13513G>A candidate mutation]. Vestn Oftalmol 138:208\u2013214","journal-title":"Vestn Oftalmol"},{"key":"285_CR5","doi-asserted-by":"crossref","first-page":"W147","DOI":"10.1093\/nar\/gkw419","volume":"44","author":"S Babicki","year":"2016","unstructured":"Babicki S, Arndt D, Marcu A, Liang Y, Grant JR, Maciejewski A, Wishart DS (2016) Heatmapper: web-enabled heat mapping for all. Nucleic Acids Res 44:W147\u2013W153","journal-title":"Nucleic Acids Res"},{"key":"285_CR6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/bs.mcb.2019.11.025","volume":"155","author":"SR Bacman","year":"2020","unstructured":"Bacman SR, Nissanka N, Moraes CT (2020) Cybrid technology. Methods Cell Biol 155:415\u2013439","journal-title":"Methods Cell Biol"},{"key":"285_CR7","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/nm.3261","volume":"19","author":"SR Bacman","year":"2013","unstructured":"Bacman SR, Williams SL, Pinto M, Peralta S, Moraes CT (2013) Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs. Nat Med 19:1111\u20131113","journal-title":"Nat Med"},{"key":"285_CR8","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/MOP.0000000000000954","volume":"32","author":"I Barcelos","year":"2020","unstructured":"Barcelos I, Shadiack E, Ganetzky RD, Falk MJ (2020) Mitochondrial medicine therapies: rationale, evidence, and dosing guidelines. Curr Opin Pediatr 32:707\u2013718","journal-title":"Curr Opin Pediatr"},{"key":"285_CR9","doi-asserted-by":"crossref","first-page":"14392","DOI":"10.1073\/pnas.0502896102","volume":"102","author":"MP Bayona-Bafaluy","year":"2005","unstructured":"Bayona-Bafaluy MP, Blits B, Battersby BJ, Shoubridge EA, Moraes CT (2005) Rapid directional shift of mitochondrial DNA heteroplasmy in animal tissues by a mitochondrially targeted restriction endonuclease. Proc Natl Acad Sci USA 102:14392\u201314397","journal-title":"Proc Natl Acad Sci USA"},{"key":"285_CR10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/07357900802350814","volume":"27","author":"N Buyru","year":"2009","unstructured":"Buyru N, Altinisik J, Ozdemir F, Demokan S, Dalay N (2009) Methylation profiles in breast cancer. Cancer Invest 27:307\u2013312","journal-title":"Cancer Invest"},{"key":"285_CR11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1158\/1078-0432.CCR-07-0722","volume":"14","author":"AL Carvalho","year":"2008","unstructured":"Carvalho AL, Jeronimo C, Kim MM, Henrique R, Zhang Z, Hoque MO, Chang S, Brait M, Nayak CS, Jiang WW et al (2008) Evaluation of promoter hypermethylation detection in body fluids as a screening\/diagnosis tool for head and neck squamous cell carcinoma. Clin Cancer Res 14:97\u2013107","journal-title":"Clin Cancer Res"},{"key":"285_CR12","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.1038\/sj.onc.1205699","volume":"21","author":"JK Christman","year":"2002","unstructured":"Christman JK (2002) 5-Azacytidine and 5-aza-2\u2019-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene 21:5483\u20135495","journal-title":"Oncogene"},{"key":"285_CR13","first-page":"265","volume":"4","author":"J Clarke","year":"2009","unstructured":"Clarke J, Wu HC, Jayasinghe L, Patel A, Reid S, Bayley H (2009) Continuous base identification for single-molecule nanopore DNA sequencing. Nat Nanotechnol 2009 4:4 4:265\u2013270","journal-title":"Nat Nanotechnol 2009 4:4"},{"key":"285_CR14","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3390\/biom14091117","volume":"14","author":"AT Davletgildeeva","year":"2024","unstructured":"Davletgildeeva AT, Kuznetsov NA (2024) The role of DNMT methyltransferases and TET dioxygenases in the maintenance of the DNA methylation level. Biomolecules 14:1117","journal-title":"Biomolecules"},{"key":"285_CR15","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1101\/gad.2037511","volume":"25","author":"AM Deaton","year":"2011","unstructured":"Deaton AM, Bird A (2011) CpG islands and the regulation of transcription. Genes Dev 25:1010\u20131022","journal-title":"Genes Dev"},{"key":"285_CR16","doi-asserted-by":"crossref","first-page":"7087","DOI":"10.1074\/jbc.275.10.7087","volume":"275","author":"R Dey","year":"2000","unstructured":"Dey R, Moraes CT (2000) Lack of oxidative phosphorylation and low mitochondrial membrane potential decrease susceptibility to apoptosis and do not modulate the protective effect of Bcl-x(L) in osteosarcoma cells. J Biol Chem 275:7087\u20137094","journal-title":"J Biol Chem"},{"key":"285_CR17","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/archneur.1993.00540110075008","volume":"50","author":"S DiMauro","year":"1993","unstructured":"DiMauro S, Moraes CT (1993) Mitochondrial encephalomyopathies. Arch Neurol 50:1197\u20131208","journal-title":"Arch Neurol"},{"key":"285_CR18","doi-asserted-by":"crossref","first-page":"S303","DOI":"10.3233\/JND-210678","volume":"8","author":"N Elangkovan","year":"2021","unstructured":"Elangkovan N, Dickson G (2021) Gene therapy for Duchenne muscular dystrophy. J Neuromuscul Dis 8:S303","journal-title":"J Neuromuscul Dis"},{"key":"285_CR19","unstructured":"Eads CA, Lord RV, Wickramasinghe K, Long TI, Kurumboor SK, Bernstein L, Peters JH, DeMeester SR, DeMeester TR, Skinner KA et al. (2001) Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res. 61:3410\u20133418."},{"key":"285_CR20","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1158\/2159-8290.CD-24-0296","volume":"14","author":"M Esteller","year":"2024","unstructured":"Esteller M, Dawson MA, Kadoch C, Rassool FV, Jones PA, Baylin SB (2024) The epigenetic hallmarks of cancer. Cancer Discov 14:1783\u20131809","journal-title":"Cancer Discov"},{"key":"285_CR21","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41582-022-00715-9","volume":"18","author":"M Falabella","year":"2022","unstructured":"Falabella M, Minczuk M, Hanna MG, Viscomi C, Pitceathly RDS (2022) Gene therapy for primary mitochondrial diseases: experimental advances and clinical challenges. Nat Rev Neurol 18:689\u2013698","journal-title":"Nat Rev Neurol"},{"key":"285_CR22","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1158\/1078-0432.CCR-13-1453","volume":"20","author":"TE Fandy","year":"2014","unstructured":"Fandy TE, Jiemjit A, Thakar M, Rhoden P, Suarez L, Gore SD (2014) Decitabine induces delayed reactive oxygen species (ROS) accumulation in leukemia cells and induces the expression of ROS generating enzymes. Clin Cancer Res 20:1249\u20131258","journal-title":"Clin Cancer Res"},{"key":"285_CR23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cophys.2020.01.004","volume":"14","author":"B Fine","year":"2020","unstructured":"Fine B, Vunjak-Novakovic G (2020) Heart regeneration in mouse and human: a bioengineering perspective. Curr Opin Physiol 14:56\u201363","journal-title":"Curr Opin Physiol"},{"key":"285_CR24","first-page":"253","volume":"13","author":"J Finsterer","year":"2023","unstructured":"Finsterer J (2023) Phenotypic heterogeneity of the mitochondrial DNA variant m.13513 G\u2009>\u2009A. J Pediatr Genet 13:253","journal-title":"J Pediatr Genet"},{"key":"285_CR25","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/1087057111421212","volume":"17","author":"JM Foulks","year":"2012","unstructured":"Foulks JM, Parnell KM, Nix RN, Chau S, Swierczek K, Saunders M, Wright K, Hendrickson TF, ho KK, Mccullar MV et al (2012) Epigenetic drug discovery: targeting DNA methyltransferases. J Biomol Screen 17:2\u201317","journal-title":"J Biomol Screen"},{"key":"285_CR26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00428-012-1348-2","volume":"462","author":"D Furlan","year":"2013","unstructured":"Furlan D, Sahnane N, Mazzoni M, Pastorino R, Carnevali I, Stefanoli M, Ferretti A, Chiaravalli AM, La Rosa S, Capella C (2013) Diagnostic utility of MS-MLPA in DNA methylation profiling of adenocarcinomas and neuroendocrine carcinomas of the colon-rectum. Virchows Arch 462:47\u201356","journal-title":"Virchows Arch"},{"key":"285_CR27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.tig.2017.11.001","volume":"34","author":"PA Gammage","year":"2017","unstructured":"Gammage PA, Moraes CT, Minczuk M (2017) Mitochondrial genome engineering: the revolution may not be CRISPR-Ized. Trends Genet 34:101\u2013110","journal-title":"Trends Genet"},{"key":"285_CR28","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/emmm.201303672","volume":"6","author":"PA Gammage","year":"2014","unstructured":"Gammage PA, Rorbach J, Vincent AI, Rebar EJ, Minczuk M (2014) Mitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutations. EMBO Mol Med 6:458\u2013466","journal-title":"EMBO Mol Med"},{"issue":"11","key":"285_CR29","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1007\/s00432-019-03016-9","volume":"145","author":"AL Gawlitza","year":"2019","unstructured":"Gawlitza AL, Speith J, Rinke J, Sajzew R, M\u00fcller EK, Sch\u00e4fer V, Hochhaus A, Ernst T (2019) 5-Azacytidine modulates CpG methylation levels of EZH2 and NOTCH1 in myelodysplastic syndromes. J Cancer Res Clin Oncol 145(11):2835\u20132843","journal-title":"J Cancer Res Clin Oncol"},{"key":"285_CR30","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.24362","volume":"77","author":"GS Gorman","year":"2015","unstructured":"Gorman GS, Schaefer AM, Ng Y, Gomez N, Blakely EL, Alston CL, Feeney C, Horvath R, Yu-Wai-Man P, Chinnery PF et al (2015) Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Ann Neurol 77:753\u2013759","journal-title":"Ann Neurol"},{"key":"285_CR31","first-page":"78","volume":"7","author":"J Guo","year":"2021","unstructured":"Guo J, Zhang X, Chen X, Sun H, Dai Y, Wang J, Qian X, Tan L, Lou X, Shen B (2021) Precision modeling of mitochondrial diseases in zebrafish via DdCBE-mediated mtDNA base editing. Cell Discov 7:78","journal-title":"Cell Discov"},{"key":"285_CR32","doi-asserted-by":"crossref","first-page":"e159419","DOI":"10.1172\/jci.insight.159419","volume":"7","author":"WR Gutierrez","year":"2022","unstructured":"Gutierrez WR, Scherer A, Rytlewski JD, Laverty EA, Sheehan AP, McGivney GR, Brockman QR, Knepper-Adrian V, Roughton GA, Quelle DE et al (2022) Augmenting chemotherapy with low-dose decitabine through an immune-independent mechanism. JCI Insight 7:e159419","journal-title":"JCI Insight"},{"key":"285_CR33","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/mt.2015.126","volume":"23","author":"M Hashimoto","year":"2015","unstructured":"Hashimoto M, Bacman SR, Peralta S, Falk MJ, Chomyn A, Chan DC, Williams SL, Moraes CT (2015) MitoTALEN: a general approach to reduce mutant mtDNA loads and restore oxidative phosphorylation function in mitochondrial diseases. Mol Ther 23:1592\u20131599","journal-title":"Mol Ther"},{"key":"285_CR34","first-page":"8837893","volume":"2020","author":"Q Jiang","year":"2020","unstructured":"Jiang Q, Yin J, Chen J, Ma X, Wu M, Liu G, Yao K, Tan B, Yin Y (2020) Mitochondria-targeted antioxidants: a step towards disease treatment. Oxid Med Cell Longev 2020:8837893","journal-title":"Oxid Med Cell Longev"},{"key":"285_CR35","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1113\/jphysiol.2004.065904","volume":"558","author":"F Kadi","year":"2004","unstructured":"Kadi F, Schjerling P, Andersen LL, Charifi N, Madsen JL, Christensen LR, Andersen JL (2004) The effects of heavy resistance training and detraining on satellite cells in human skeletal muscles. J Physiol 558:1005\u20131012","journal-title":"J Physiol"},{"key":"285_CR36","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1093\/brain\/awh515","volume":"128","author":"M K\u00e4rpp\u00e4","year":"2005","unstructured":"K\u00e4rpp\u00e4 M, Herva R, Moslemi AR, Oldfors A, Kakko S, Majamaa K (2005) Spectrum of myopathic findings in 50 patients with the 3243A>G mutation in mitochondrial DNA. Brain 128:1861\u20131869","journal-title":"Brain"},{"key":"285_CR37","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1016\/j.celrep.2016.08.037","volume":"16","author":"JHK Kauppila","year":"2016","unstructured":"Kauppila JHK, Baines HL, Bratic A, Simard ML, Freyer C, Mourier A, Stamp C, Filograna R, Larsson NG, Greaves LC et al (2016) A phenotype-driven approach to generate mouse models with pathogenic mtDNA mutations causing mitochondrial disease. Cell Rep 16:2980\u20132990","journal-title":"Cell Rep"},{"key":"285_CR38","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3390\/biomedicines11020532","volume":"11","author":"VA Khotina","year":"2023","unstructured":"Khotina VA, Vinokurov AY, Bagheri Ekta M, Sukhorukov VN, Orekhov AN (2023) Creation of mitochondrial disease models using mitochondrial DNA editing. Biomedicines 11:532","journal-title":"Biomedicines"},{"key":"285_CR39","doi-asserted-by":"crossref","first-page":"16028","DOI":"10.1073\/pnas.1906896116","volume":"116","author":"PK Kopinski","year":"2019","unstructured":"Kopinski PK, Janssen KA, Schaefer PM, Trefely S, Perry CE, Potluri P, Tintos-Hernandez JA, Singh LN, Karch KR, Campbell SL et al (2019) Regulation of nuclear epigenome by mitochondrial DNA heteroplasmy. Proc Natl Acad Sci USA 116:16028\u201316035","journal-title":"Proc Natl Acad Sci USA"},{"key":"285_CR40","doi-asserted-by":"crossref","first-page":"843","DOI":"10.2217\/epi-2016-0002","volume":"8","author":"S Kreuz","year":"2016","unstructured":"Kreuz S, Fischle W (2016) Oxidative stress signaling to chromatin in health and disease. Epigenomics 8:843\u2013862","journal-title":"Epigenomics"},{"key":"285_CR41","volume":"23","author":"S Lee","year":"2022","unstructured":"Lee S, Lee H, Baek G, Namgung E, Park JM, Kim S, Hong S, Kim JS (2022) Enhanced mitochondrial DNA editing in mice using nuclear-exported TALE-linked deaminases and nucleases. Genome Biol 23:211","journal-title":"Genome Biol"},{"key":"285_CR42","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1006\/excr.1999.4407","volume":"248","author":"H Lochm\u00fcller","year":"1999","unstructured":"Lochm\u00fcller H, Johns T, Shoubridge EA (1999) Expression of the E6 and E7 genes of human papillomavirus (HPV16) extends the life span of human myoblasts. Exp Cell Res 248:186\u2013193","journal-title":"Exp Cell Res"},{"key":"285_CR43","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.3390\/ijms21165598","volume":"21","author":"Y Luo","year":"2020","unstructured":"Luo Y, Ma J, Lu W (2020) The significance of mitochondrial dysfunction in cancer. Int J Mol Sci 21:5598","journal-title":"Int J Mol Sci"},{"key":"285_CR44","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s12253-018-0398-4","volume":"24","author":"I Maleva Kostovska","year":"2018","unstructured":"Maleva Kostovska I, Jakimovska M, Popovska-Jankovic K, Kubelka-Sabit K, Karagjozov M, Plaseska-Karanfilska D (2018) TIMP3 promoter methylation represents an epigenetic marker of BRCA1ness breast cancer tumours. Pathol Oncol Res 24:937\u2013940","journal-title":"Pathol Oncol Res"},{"key":"285_CR45","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.tcb.2017.02.004","volume":"27","author":"O Matilainen","year":"2017","unstructured":"Matilainen O, Quir\u00f3s PM, Auwerx J (2017) Mitochondria and epigenetics\u2014 crosstalk in homeostasis and stress. Trends Cell Biol 27:453\u2013463","journal-title":"Trends Cell Biol"},{"key":"285_CR46","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00018-019-03008-5","volume":"76","author":"L Mayorga","year":"2019","unstructured":"Mayorga L, Salassa BNBN, Marzese DMDM, Loos MAMA, Eiroa HDHD, Lubieniecki F, Garc\u00eda, Samartino C, Romano PSPS, Roqu\u00e9 M (2019) Mitochondrial stress triggers a pro-survival response through epigenetic modifications of nuclear DNA. Cell Mol Life Sci 76:1397\u20131417","journal-title":"Cell Mol Life Sci"},{"key":"285_CR47","doi-asserted-by":"crossref","unstructured":"Mok BY, Moraes MHD, Zeng J, Bosch DE, Kotrys AV, Raguram A, Hsu F, Radey MC, Peterson SB, Mootha VK et al (2020) A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing. Nature 583:631\u2013637","DOI":"10.1038\/s41586-020-2477-4"},{"key":"285_CR48","doi-asserted-by":"crossref","first-page":"R92","DOI":"10.1093\/hmg\/ddae037","volume":"33","author":"CT Moraes","year":"2024","unstructured":"Moraes CT (2024) Tools for editing the mammalian mitochondrial genome. Hum Mol Genet 33:R92\u2013R99","journal-title":"Hum Mol Genet"},{"key":"285_CR49","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-018-0151-x","volume":"6","author":"MJ Morris","year":"2018","unstructured":"Morris MJ, Hesson LB, Poulos RC, Ward RL, Wong JWH, Youngson NA (2018) Reduced nuclear DNA methylation and mitochondrial transcript changes in adenomas do not associate with mtDNA methylation. Biomark Res 6:37","journal-title":"Biomark Res"},{"key":"285_CR50","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0960-8966(98)00029-7","volume":"8","author":"AR Moslemi","year":"1998","unstructured":"Moslemi AR, Tulinius M, Holme E, Oldfors A (1998) Threshold expression of the tRNA(Lys) A8344G mutation in single muscle fibres. Neuromuscul Disord 8:345\u2013349","journal-title":"Neuromuscul Disord"},{"key":"285_CR51","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1093\/brain\/awn252","volume":"131","author":"JL Murphy","year":"2008","unstructured":"Murphy JL, Blakely EL, Schaefer AM, He L, Wyrick P, Haller RG, Taylor RW, Turnbull DM, Taivassalo T (2008) Resistance training in patients with single, large-scale deletions of mitochondrial DNA. Brain 131:2832\u20132840","journal-title":"Brain"},{"key":"285_CR52","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1182\/blood.2022016029","volume":"140","author":"X Ni","year":"2022","unstructured":"Ni X, Wang L, Wang H, Yu T, Xie J, Li G, Liu Y, Zhou H, Xu M, Hou M et al (2022) Low-dose decitabine modulates myeloid-derived suppressor cell fitness via LKB1 in immune thrombocytopenia. Blood 140:2818\u20132834","journal-title":"Blood"},{"key":"285_CR53","first-page":"1","volume":"33","author":"AOH Nygren","year":"2005","unstructured":"Nygren AOH, Ameziane N, Duarte HMB, Vijzelaar RNCP, Waisfisz Q, Hess CJ, Schouten JP, Errami A (2005) Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences. Nucleic Acids Res 33:1\u20139","journal-title":"Nucleic Acids Res"},{"key":"285_CR54","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1158\/0008-5472.CAN-18-1255","volume":"79","author":"MAL Osuna","year":"2019","unstructured":"Osuna MAL, Garcia-Lopez J, Ayachi IE, Fatima I, Khalid AB, Kumpati J, Slayden AV, Seagroves TN, Miranda-Carboni GA, Krum SA (2019) Activation of estrogen receptor alpha by decitabine inhibits osteosarcoma growth and metastasis. Cancer Res 79:1054\u20131068","journal-title":"Cancer Res"},{"key":"285_CR55","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1128\/MCB.06147-11","volume":"31","author":"L Peng","year":"2011","unstructured":"Peng L, Yuan Z, Ling H, Fukasawa K, Robertson K, Olashaw N, Koomen J, Chen J, Lane WS, Seto E (2011) SIRT1 deacetylates the DNA methyltransferase 1 (DNMT1) protein and alters its activities. Mol Cell Biol 31:4720\u20134734","journal-title":"Mol Cell Biol"},{"key":"285_CR56","first-page":"E4033","volume":"111","author":"M Picard","year":"2014","unstructured":"Picard M, Zhang J, Hancock S, Derbeneva O, Golhar R, Golik P, O\u2019Hearn S, Levy S, Potluri P, Lvova M et al (2014) Progressive increase in mtDNA 3243A>G heteroplasmy causes abrupt transcriptional reprogramming. Proc Natl Acad Sci USA 111:E4033\u2013E4042","journal-title":"Proc Natl Acad Sci USA"},{"key":"285_CR57","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-016-1066-1","volume":"17","author":"R Pidsley","year":"2016","unstructured":"Pidsley R, Zotenko E, Peters TJ, Lawrence MG, Risbridger GP, Molloy P, Van Djik S, Muhlhausler B, Stirzaker C, Clark SJ (2016) Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling. Genome Biol 17:208","journal-title":"Genome Biol"},{"key":"285_CR58","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1126\/science.6254144","volume":"210","author":"A Razin","year":"1980","unstructured":"Razin A, Riggs AD (1980) DNA methylation and gene function. Science 210:604\u2013610","journal-title":"Science"},{"key":"285_CR59","doi-asserted-by":"crossref","first-page":"1015388","DOI":"10.3389\/fendo.2022.1015388","volume":"13","author":"T Reinert","year":"2022","unstructured":"Reinert T, Cascelli F, Resende CAAD, Gon\u00e7alves AC, Godo VSP, Barrios CH (2022) Clinical implication of low estrogen receptor (ER-low) expression in breast cancer. Front Endocrinol 13:1015388","journal-title":"Front Endocrinol"},{"key":"285_CR60","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3389\/fncel.2022.916065","volume":"16","author":"W Rossoll","year":"2022","unstructured":"Rossoll W, Singh RN (2022) Commentary: current status of gene therapy for spinal muscular atrophy. Front Cell Neurosci 16:930\u2013940","journal-title":"Front Cell Neurosci"},{"key":"285_CR61","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1089\/crispr.2021.0061","volume":"4","author":"A Sabharwal","year":"2021","unstructured":"Sabharwal A, Kar B, Restrepo-Castillo S, Holmberg SR, Mathew ND, Kendall BL, Cotter RP, Warejoncas Z, Seiler C, Nakamaru-Ogiso E et al (2021) The FusX TALE base editor (FusXTBE) for rapid mitochondrial DNA programming of human cells in vitro and zebrafish disease models in vivo. CRISPR J 4:799\u2013821","journal-title":"CRISPR J"},{"key":"285_CR62","doi-asserted-by":"crossref","first-page":"120375","DOI":"10.1016\/j.lfs.2022.120375","volume":"294","author":"N Sayed","year":"2022","unstructured":"Sayed N, Allawadhi P, Khurana A, Singh V, Navik U, Pasumarthi SK, Khurana I, Banothu AK, Weiskirchen R, Bharani KK (2022) Gene therapy: comprehensive overview and therapeutic applications. Life Sci 294:120375","journal-title":"Life Sci"},{"key":"285_CR63","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ana.21217","volume":"63","author":"AM Schaefer","year":"2008","unstructured":"Schaefer AM, McFarland R, Blakely EL, He L, Whittaker RG, Taylor RW, Chinnery PF, Turnbull DM (2008) Prevalence of mitochondrial DNA disease in adults. Ann Neurol 63:35\u201339","journal-title":"Ann Neurol"},{"key":"285_CR64","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-21794-0","volume":"12","author":"L Schmiderer","year":"2022","unstructured":"Schmiderer L, Yudovich D, Oburoglu L, Hjort M, Larsson J (2022) Site-specific CRISPR-based mitochondrial DNA manipulation is limited by gRNA import. Sci Rep 12:18687","journal-title":"Sci Rep"},{"key":"285_CR65","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3389\/fgene.2019.00868","volume":"10","author":"A Shahryari","year":"2019","unstructured":"Shahryari A, Jazi MS, Mohammadi S, Nikoo HR, Nazari Z, Hosseini ES, Burtscher I, Mowla SJ, Lickert H (2019) Development and clinical translation of approved gene therapy products for genetic disorders. Front Genet 10:868","journal-title":"Front Genet"},{"key":"285_CR66","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/archpedi.155.11.1210","volume":"155","author":"AL Shanske","year":"2001","unstructured":"Shanske AL, Shanske S, DiMauro S (2001) The other human genome. Arch Pediatr Adolesc Med 155:1210\u20131216","journal-title":"Arch Pediatr Adolesc Med"},{"key":"285_CR67","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1001\/archneurol.2007.67","volume":"65","author":"S Shanske","year":"2008","unstructured":"Shanske S, Coku J, Lu J, Ganesh J, Krishna S, Tanji K, Bonilla E, Naini AB, Hirano M, DiMauro S (2008) The G13513A mutation in the ND5 gene of mitochondrial DNA as a common cause of MELAS or Leigh syndrome: evidence from 12 cases. Arch Neurol 65:368\u2013372","journal-title":"Arch Neurol"},{"key":"285_CR68","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0092-8674(90)90059-N","volume":"61","author":"JM Shoffner","year":"1990","unstructured":"Shoffner JM, Lott MT, Lezza AMS, Seibel P, Ballinger SW, Wallace DC (1990) Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell 61:931\u2013937","journal-title":"Cell"},{"key":"285_CR69","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1038\/s42255-023-00932-6","volume":"5","author":"WK Shoop","year":"2023","unstructured":"Shoop WK, Lape J, Trum M, Powell A, Sevigny E, Mischler A, Bacman SR, Fontanesi F, Smith J, Jantz D et al (2023) Efficient elimination of MELAS-associated m.3243G mutant mitochondrial DNA by an engineered mitoARCUS nuclease. Nat Metab 5:2169\u20132183","journal-title":"Nat Metab"},{"key":"285_CR70","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1212\/WNL.43.6.1200","volume":"43","author":"G Silvestri","year":"1993","unstructured":"Silvestri G, Ciafaloni E, Santorelli FM, Shanske S, Servidei S, Graf WD, Sumi M, DiMauro S (1993) Clinical features associated with the A->G transition at nucleotide 8344 of mtDNA (\u2018MERRF mutation\u2019). Neurology 43:1200\u20131206","journal-title":"Neurology"},{"key":"285_CR71","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1093\/hmg\/10.26.3093","volume":"10","author":"S Srivastava","year":"2001","unstructured":"Srivastava S, Moraes CT (2001) Manipulating mitochondrial DNA heteroplasmy by a mitochondrially targeted restriction endonuclease. Hum Mol Genet 10:3093\u20133099","journal-title":"Hum Mol Genet"},{"key":"285_CR72","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.3390\/ijms22094594","volume":"22","author":"A Stoccoro","year":"2021","unstructured":"Stoccoro A, Copped\u00e8 F (2021) Mitochondrial dna methylation and human diseases. Int J Mol Sci 22:4594","journal-title":"Int J Mol Sci"},{"key":"285_CR73","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ijc.23607","volume":"123","author":"C Stresemann","year":"2008","unstructured":"Stresemann C, Lyko F (2008) Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine. Int J Cancer 123:8\u201313","journal-title":"Int J Cancer"},{"key":"285_CR74","doi-asserted-by":"crossref","first-page":"e1009524","DOI":"10.1371\/journal.pcbi.1009524","volume":"17","author":"S Su","year":"2021","unstructured":"Su S, Gouil Q, Blewitt ME, Cook D, Hickey PF, Ritchie ME (2021) NanoMethViz: an R\/Bioconductor package for visualizing long-read methylation data. PLoS Comput Biol 17:e1009524","journal-title":"PLoS Comput Biol"},{"key":"285_CR75","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s10038-003-0116-1","volume":"49","author":"A Sudo","year":"2004","unstructured":"Sudo A, Honzawa S, Nonaka I, Goto YI (2004) Leigh syndrome caused by mitochondrial DNA G13513A mutation: frequency and clinical features in Japan. J Hum Genet 49:92\u201396","journal-title":"J Hum Genet"},{"key":"285_CR76","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.aninu.2015.08.004","volume":"1","author":"B Tan","year":"2015","unstructured":"Tan B, Xiao H, Li F, Zeng L, Yin Y (2015) The profiles of mitochondrial respiration and glycolysis using extracellular flux analysis in porcine enterocyte IPEC-J2. Anim Nutr 1:239\u2013243","journal-title":"Anim Nutr"},{"key":"285_CR77","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1023\/B:BOLI.0000031098.41409.55","volume":"27","author":"DR Thorburn","year":"2004","unstructured":"Thorburn DR (2004) Mitochondrial disorders: prevalence, myths and advances. J Inherit Metab Dis 27:349\u2013362","journal-title":"J Inherit Metab Dis"},{"key":"285_CR78","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.3892\/mmr.2017.7264","volume":"16","author":"H Tong","year":"2017","unstructured":"Tong H, Zhang L, Gao J, Wen S, Zhou H, Feng S (2017) Methylation of mitochondrial DNA displacement loop region regulates mitochondrial copy number in colorectal cancer. Mol Med Rep 16:5347\u20135353","journal-title":"Mol Med Rep"},{"key":"285_CR79","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.4103\/NRR.NRR-D-24-00901","volume":"20","author":"S Vidman","year":"2025","unstructured":"Vidman S, Ma YHE, Fullenkamp N, Plant GW (2025) Human induced pluripotent stem cell-derived therapies for regeneration after central nervous system injury. Neural Regen Res 20:3063\u20133075","journal-title":"Neural Regen Res"},{"key":"285_CR80","first-page":"616","volume":"27","author":"K Wang","year":"2010","unstructured":"Wang K, Yan CZ, Wang GX, Jiao JS, Jin M (2010) Mitochondrial ND5 as the causative gene of Leight syndrome. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 27:616\u2013619","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"key":"285_CR81","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/acn3.51787","volume":"10","author":"W Wang","year":"2023","unstructured":"Wang W, Zhao Y, Xu X, Ma X, Sun Y, Lin Y, Zhao Y, Xu Z, Wang J, Ren H et al (2023) A different pattern of clinical, muscle pathology and brain MRI findings in MELAS with mt-ND variants. Ann Clin Transl Neurol 10:1035\u20131045","journal-title":"Ann Clin Transl Neurol"},{"key":"285_CR82","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3233\/CBM-150543","volume":"16","author":"J Yang","year":"2016","unstructured":"Yang J, Xiao X, Li R, Li Z, Deng M, Zhang G (2016) Hypermethylation of CpG sites at the promoter region is associated with deregulation of mitochondrial ATPsyn-? and chemoresistance in acute myeloid leukemia. Cancer Biomark 16:81\u201388","journal-title":"Cancer Biomark"},{"key":"285_CR83","first-page":"203","volume":"48","author":"M Zeviani","year":"1991","unstructured":"Zeviani M, Amati P, Bresolin N, Antozzi C, Piccolo G, Toscano A, DiDonato S (1991) Rapid detection of the A\u2192G((8344)) mutation of mtDNA in Italian families with myoclonus epilepsy and ragged-red fibers (MERRF). Am J Hum Genet 48:203\u2013211","journal-title":"Am J Hum Genet"},{"key":"285_CR84","doi-asserted-by":"crossref","first-page":"20691","DOI":"10.18632\/oncotarget.7842","volume":"7","author":"W Zhou","year":"2016","unstructured":"Zhou W, Tian D, He J, Wang Y, Zhang L, Cui L, Jia L, Zhang L, Li L, Shu Y et al (2016) Repeated PM2.5 exposure inhibits BEAS-2B cell P53 expression through ROS-Akt-DNMT3B pathway-mediated promoter hypermethylation. Oncotarget 7:20691\u201320703","journal-title":"Oncotarget"},{"key":"285_CR85","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK (2019) Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun 10:1523","journal-title":"Nat Commun"},{"key":"285_CR86","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s11596-020-2266-1","volume":"40","author":"XY Zhu","year":"2020","unstructured":"Zhu XY, Liu W, Liang HT, Tang L, Zou P, You Y, Zhu XJ (2020) AICAR and decitabine enhance the sensitivity of K562 cells to imatinib by promoting mitochondrial activity. Curr Med Sci 40:871\u2013878","journal-title":"Curr Med Sci"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00285-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-025-00285-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00285-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:03:50Z","timestamp":1786979030000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-025-00285-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":86,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9,11]]}},"alternative-id":["285"],"URL":"https:\/\/doi.org\/10.1038\/s44321-025-00285-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.12.30.630791","asserted-by":"object"}]},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"1 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}],"article-number":"10"}}